2005年7月第14期
·07/05/08 Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
·07/05/08 Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes
·07/05/08 Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
·07/05/08 Transforming growth factor-1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12
·07/05/08 Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
·07/05/08 Tie2 activation contributes to hemangiogenic regeneration after myelosuppression
·07/05/08 Zygotic nucleosome assembly protein–like 1 has a specific, non–cell autonomous role in hematopoiesis
·07/05/08 Identification of novel vascular endothelial–specific genes by the microarray analysis of the zebrafish cloche mutants
·07/05/08 A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome
·07/05/08 Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKC in platelets
·07/05/08 Quiescence and functional reprogramming of epstein-Barr virus (eBV)–specific CD8+ T cells during persistent infection
·07/05/08 Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
·07/05/08 NK-dependent DC maturation is mediated by TNF and IFN released upon engagement of the NKp30 triggering receptor
·07/05/08 Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia
·07/05/08 Arf6: a new player in FcRIIIA lymphocyte-mediated cytotoxicity
·07/05/08 ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF--activated vascular endothelium under flow
·07/05/08 Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils
·07/05/08 Ligand-induced conformational change in the T-cell receptor associated with productive immune synapses
·07/05/08 Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)–negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaero
·07/05/08 NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1
·07/05/08 Vav proteins are required for B-lymphocyte responses to LPS
·07/05/08 Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries
·07/05/08 Indole-3-carbinol suppresses NF-B and IB kinase activation, causing inhibition of expression of NF-B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and le
·07/05/08 The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia
·07/05/08 Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/v3 in promyelocytic leukemia NB4 cells
·07/05/08 Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database
·07/05/08 Internal tandem duplications of the FLT3 gene are present in leukemia stem cells
·07/05/08 The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
·07/05/08 Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia
·07/05/08 The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells
·07/05/08 SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma
·07/05/08 Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer
·07/05/08 CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism
·07/05/08 A clinically relevant SCID-hu in vivo model of human multiple myeloma
·07/05/08 Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
·07/05/08 Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes
·07/05/08 Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
·07/05/08 Transforming growth factor-1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12
·07/05/08 Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
·07/05/08 Tie2 activation contributes to hemangiogenic regeneration after myelosuppression
·07/05/08 Zygotic nucleosome assembly protein–like 1 has a specific, non–cell autonomous role in hematopoiesis
·07/05/08 Identification of novel vascular endothelial–specific genes by the microarray analysis of the zebrafish cloche mutants
·07/05/08 A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome
·07/05/08 Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKC in platelets
·07/05/08 Quiescence and functional reprogramming of epstein-Barr virus (eBV)–specific CD8+ T cells during persistent infection
·07/05/08 Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
·07/05/08 NK-dependent DC maturation is mediated by TNF and IFN released upon engagement of the NKp30 triggering receptor
·07/05/08 Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia
·07/05/08 Arf6: a new player in FcRIIIA lymphocyte-mediated cytotoxicity
·07/05/08 ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF--activated vascular endothelium under flow
·07/05/08 Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils
·07/05/08 Ligand-induced conformational change in the T-cell receptor associated with productive immune synapses
·07/05/08 Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)–negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaero
·07/05/08 NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1
·07/05/08 Vav proteins are required for B-lymphocyte responses to LPS
·07/05/08 Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries
·07/05/08 Indole-3-carbinol suppresses NF-B and IB kinase activation, causing inhibition of expression of NF-B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and le
·07/05/08 The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia
·07/05/08 Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/v3 in promyelocytic leukemia NB4 cells
·07/05/08 Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database
·07/05/08 Internal tandem duplications of the FLT3 gene are present in leukemia stem cells
·07/05/08 The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
·07/05/08 Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia
·07/05/08 The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells
·07/05/08 SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma
·07/05/08 Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer
·07/05/08 CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism
·07/05/08 A clinically relevant SCID-hu in vivo model of human multiple myeloma
·07/05/08 Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
栏目列表
·2005年7月第13期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期